Moderna Shares Gain 18% in a Week, Reach Four-Year High
Moderna shares rose 18% last week, finishing at their highest level in more than four years. The move followed a New York Times report that the NIH is planning a public-private effort to speed up cancer vaccines.
Moderna shares rose 18% last week, ending at their highest level in more than four years. The move followed a Friday report by The New York Times that the National Institutes of Health is planning a public-private effort to accelerate cancer vaccines. Moderna stock also joined the Nasdaq-100…